Expanded Access to Ziftomenib

Clinical trial NCT05738538 · AVAILABLE

Trial details

NCT number: NCT05738538
Sponsor: Kura Oncology, Inc.
Status: AVAILABLE
Study type: EXPANDED_ACCESS

Acute Lymphoblastic Leukemia, With KMT2A Rearrangements Acute Myeloid Leukemia, With NPM1 Mutations Acute Myeloid Leukemia, With KMT2A Rearrangements

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.